0001658551-18-000001.txt : 20181120 0001658551-18-000001.hdr.sgml : 20181120 20181120120430 ACCESSION NUMBER: 0001658551-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181120 DATE AS OF CHANGE: 20181120 EFFECTIVENESS DATE: 20181120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326193 FILM NUMBER: 181194823 BUSINESS ADDRESS: STREET 1: 210 BROADWAY STREET 2: #201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-571-8872 MAIL ADDRESS: STREET 1: 210 BROADWAY STREET 2: #201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001658551 Amylyx Pharmaceuticals, Inc. 210 BROADWAY #201 CAMBRIDGE MA MASSACHUSETTS 02139 617-683-0917 DELAWARE None None Corporation true 2014 Joshua Cohen 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Justin Klee 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Stephen Chubb 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director George Milne 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director Peter Finn c/o Rubin and Rudman LLP 53 State Street Boston MA MASSACHUSETTS 02110 Executive Officer Walter Gilbert 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director Isaac Cheng 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director Felix Von Coerper 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2018-11-14 false true false 10000 12978100 12978100 0 false 32 0 0 360000 true Executive Compensation false Amylyx Pharmaceuticals, Inc. Peter B. Finn Peter B. Finn Secretary 2018-11-20